ORPHA:2978
Chronic intestinal pseudoobstruction syndrome
Also known as: CIPO · CIPO syndrome · CIPS · CIP syndrome
Publications
1,729
Trials
6
Interventional, condition-specific
Researchers
1,239
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare and heterogeneous gastroenterological clinical syndrome characterized by recurrent symptoms of intestinal obstruction with radiological features of dilated small or large intestine in absence of any mechanical occlusive lesion. Permanent alterations in neural, muscular, or mesenchymal structures of the intestinal wall or its extrinsic neural control, chronically impair tonic and propulsive motor functions in one or more segments of the gut.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0017574
- UMLS:C0238062
Additional Mondo synonyms (4)
Chronic Intestinal Pseudo-Obstruction · chronic intestinal pseudo-obstruction · cipo · intestinal pseudo-obstruction, chronic
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,729 matched papers (856 in last 10 years) Source
- Phenotype characterisedPresent
52 HPO annotations (e.g. Patent ductus arteriosus; Intestinal malrotation; Abnormal platelet morphology) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
6 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
52
Associated phenotypes · MONDO:0017574
- Patent ductus arteriosus
- Intestinal malrotation
- Abnormal platelet morphology
- Pyloric stenosis
- Abnormal intestine morphology
Showing 5 of 52 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,729
1,729 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,729 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
856 in the last 10 years · low confidence
Phrase hits: 1,729 · MeSH hits: 0
Who's working on it?
1,239
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01De Giorgio R9 papers · 2026
Department of Translational Medicine, University of Ferrara, Ferrara, Italy. dgrrrt@unife.it.
Papers in Europe PMC - 02Stanghellini V7 papers · 2026
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Papers in Europe PMC - 03Takahashi K7 papers · 2026
Division of Gastroenterology, Graduate School of Medical and Dental Sciences, Niigata University, 757-1, Asahimachidori, Chuo-ku, Niigata-city, Niigata, 951-8510, Japan.
Papers in Europe PMC - 04Costanzini A6 papers · 2026
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Papers in Europe PMC - 05Bonora E5 papers · 2026
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Papers in Europe PMC - 06Basilisco G4 papers · 2025
Gastroenterologia ed Endoscopia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Papers in Europe PMC - 07Kessoku T4 papers · 2026
Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan.
Papers in Europe PMC - 08Malagelada C4 papers · 2026
Digestive System Research Unit, Department of Digestive Diseases, Vall d'Hebron University Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Barcelona, Spain; Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
Papers in Europe PMC - 09Nakajima A4 papers · 2026
Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan.
Papers in Europe PMC - 10Park SH4 papers · 2025
Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
6
interventional trials for this specific condition
6 interventional trials matched this specific condition name; 1 currently recruiting in our sample.
Data as of 11 September 2026
6 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 90.1th percentile).
low confidence · 90.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
6 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06943417·NOT YET RECRUITING·Safety and Efficacy of Endoscopic Full Thickness Biopsy in Patients With Chronic Intestinal Pseudo-obstruction
Not reviewed·Conditions: Chronic Intestinal Pseudo-obstruction·Matched via name phrase
Observational and natural-history studies
4 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT04506593·RECRUITING·Indiana University Gastrointestinal Motility Diagnosis Registry
Not reviewed·Conditions: Eosinophilic Esophagitis · Gastroesophageal Reflux Disease (GERD) · Gastroparesis · Functional Vomiting·Matched via name phrase
- NCT07448753·ENROLLING BY INVITATION·ACTG2/FLNA Testing Yield in Adult Idiopathic Chronic Intestinal Pseudo-Obstruction (CIPO) With Reduced/Absent Distal Esophageal Contractility
Not reviewed·Conditions: Pseudo Obstruction·Matched via name phrase
- NCT06610929·NOT YET RECRUITING·Intestinal Microbiota and Visceral Pain in Chronic Intestinal Pseudo-Obstruction Syndrome (CIPO)
Not reviewed·Conditions: Intestinal Obstruction·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 6 · after dedupe 6 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 6 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (6)
- isrctn·ISRCTN15276264·No longer recruiting·Randomized comparison between two dry eye treatments
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15487707·No longer recruiting·Efficacy and safety of a hyaluronic acid-containing cream in the treatment of chronic, venous, or mixed-origin leg ulcers: a prospective, multicenter, randomized, controlled trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10063734·Stopped·Can eye drops effectively treat dry eye disease?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN55277999·No longer recruiting·In vivo isolation of circulating tumor cells from peripheral blood of patients with lung cancer by using a structured antibody-coated nanodetector
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10403616·No longer recruiting·Isolation of circulating tumor cells from the blood of prostate cancer patients using an antibody-coated nanodetector
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66203697·No longer recruiting·In vivo isolation of circulating tumor cells from peripheral blood of patients with breast cancer by using a structured antibody-coated nanodetector
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Chronic intestinal pseudoobstruction syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Chronic intestinal pseudoobstruction syndrome" OR "CIPO syndrome" OR "CIP syndrome" OR "Chronic Intestinal Pseudo-Obstruction" OR "intestinal pseudo-obstruction, chronic"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Chronic intestinal pseudoobstruction syndrome" OR "CIPO syndrome" OR "CIP syndrome" OR "Chronic Intestinal Pseudo-Obstruction" OR "intestinal pseudo-obstruction, chronic"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 6 interventional · 4 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: CIPO; CIPS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 2 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (1729) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T21:54:10.540Z
